TFS Capital’s Kindred Biosciences KIN Stock Holding History
Bought
Maintained
Sold
Other funds holding KIN
TFS Capital's KIN Position: Q3 2017 in Review
TFS Capital sold out of Kindred Biosciences (KIN) in Q3 2017, closing a stake of 36,157 shares — an estimated $311K sold.
TFS Capital first reported a position in KIN in Q1 2014 and held it in 7 quarters. The position peaked at $346K in Q3 2014. 67 funds tracked by Wall St. Rank hold KIN as of Q3 2017.
- TFS Capital reported no remaining Kindred Biosciences position as of Q3 2017 after selling out during the quarter.
- TFS Capital sold 36,157 Kindred Biosciences shares in Q3 2017, an estimated $311K.
- TFS Capital first reported a position in Kindred Biosciences in Q1 2014 and held it in 7 quarters.
- TFS Capital's Kindred Biosciences position peaked at $346K in Q3 2014.
- 67 funds tracked by Wall St. Rank held Kindred Biosciences as of Q3 2017.
Based on TFS Capital's 13F filing for Q3 2017.